DocGo Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $322.2M | $616.6M | $624.3M | $440.5M | $318.7M |
| Cost of revenue | — | — | — | $523.9M | $451.7M |
| Research and development | $13.6M | $11.6M | $10.9M | $5.4M | $3.3M |
| Operating expenses | $500.2M | $587.9M | $609.2M | $418.7M | $303.4M |
| Operating income | -$178.0M | $28.7M | $15.1M | $21.8M | $15.4M |
| Pretax income | -$187.5M | $27.7M | $16.3M | $22.8M | $19.8M |
| Income tax expense | $8.9M | $14.4M | $6.2M | -$8.0M | $615,697 |
| Net income | -$182.4M | $20.0M | $6.9M | $34.6M | $23.7M |
| Balance Sheet | |||||
| Cash and equivalents | $51.0M | $89.2M | $59.3M | $157.3M | $175.5M |
| Current assets | $152.4M | $304.5M | $338.9M | $271.1M | $256.0M |
| Total assets | $217.1M | $455.6M | $490.5M | $393.3M | $309.6M |
| Current liabilities | $67.5M | $121.8M | $170.1M | $100.2M | $57.9M |
| Total liabilities | $91.2M | $140.4M | $185.3M | $114.4M | $82.5M |
| Stockholders' equity | $144.0M | $320.9M | $300.8M | $273.2M | $219.6M |
| Cash Flow Statement | |||||
| Cash from operations | $34.5M | $70.1M | -$64.5M | $28.9M | -$1.9M |
| Depreciation and amortization | $15.7M | $15.9M | $16.4M | $10.6M | $2.3M |
| Stock-based compensation | $17.4M | $13.6M | $21.0M | $8.1M | $1.4M |
| Capital expenditure | $4.5M | $3.6M | $7.3M | $3.2M | $4.8M |
| Free cash flow | $29.9M | $66.5M | -$71.8M | $25.7M | -$6.8M |
| Share repurchases | $10.8M | $13.8M | $0 | $3.7M | $0 |
| Impairments | $58.2M | $0 | $0 | $2.9M | $0 |
Shares outstanding 98.8M · Free float 91.7%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.